Abstract��Three-dimensional (3D) printing is regarded as the third industrial revolution. It includes a wide variety of manufacturing techniques, which are all based on digitally-controlled depositing of materials(layer-by-layer)to create freeform geometries. It is rapidly developed in various areas including space field, architecture, manufacturing, and pharmaceutical industry. From a medical and therapeutic perspective, 3D printing is of great potential advantage for producing personalized medicines owing to its accurate control of drug structure, precise drug loading. This paper aims to review three different 3D printing technologies that can be used in pharmaceutics,including inkjet printing, fused-deposition modeling, and stereolithography apparatus to manufacture personalized tablets, implants, drug-containing microneedles, and films. Pharmaceutics is seeing a turning point and that 3D printing ofpersonalized medicines and customized dosage forms is set to revolutionize the drug delivery.
Ф�Ʒ�������������. 3D��ӡ�ĸ��Ի�ҩ���о���չ[J]. �й�ҩѧ��־, 2017, 52(2): 89-95.
XIAO Yun-fang, WANG Bo, LIN Rong. Progress in Personalized Drugs Manufactured by 3D Printing. Chinese Pharmaceutical Journal, 2017, 52(2): 89-95.
YU D G, YANG X L, XU H B, et al. Application of three-dimensional printing in pharmaceutics. Chin J New Drugs(�й���ҩ��־),2005(7):843-848.
[2]
VENTOLA C L.Medical applications for 3D printing: current and projected uses.P T, 2014,39(10):704-711.
[3]
WANG Z H, LI Y F, ZHANG M Y.The current situation and development ideas of China 3D printing industry.Econ Rev(�����ݺ�),2013,10(1): 90-94.
[4]
JONATHAN G, KARIM A. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm, 2016,499(1-2):376-394.
[5]
URSAN I D, CHIU L, PIERCE A. Three-dimensional drug printing: a structured review. J Am Pharm Assoc, 2013,53(2):136-144.
[6]
FU B. Progress and trends in ink-jet printing technology. J Inf Rec Mater(��Ϣ��¼����),2002,3(3):36-42.
[7]
HE C L, TANG Z H, TIAN H Y,et al. Advances in 3D printing technology to prepare biomedical polymer materials. Acta Polym Sin( �߷���ѧ��), 2013,52(6):722-732.
[8]
SCOUTARIS N, ROSS S, DOUROUMIS D. Current trends on medical and pharmaceutical applications of inkjet printing technology. Pharm Res, 2016,33(8):1799-1816.
[9]
MENG Q H,WANG G Q, JIANG D H. The application of ink-jet method on 3D manufacturing. J Inf Rec Mater (��Ϣ��¼����),2013,14(5):41-51. YU D G, SHEN X X, BRANFORD-WHITE C, et al. Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by three-dimensional printing. J Pharm Pharmacol, 2009,61(3):323-329. WANG X,ZHANG C, PING Q N. Advances of 3D printing technology in advanced pharmaceutical preparations. J China Pharm Univ (�й�ҩ�ƴ�ѧѧ��), 2016(2):140-147. YU D G, YANG X L, WANG Y G. Zero-order controlled-release tablets of helicid fabricated by three dimensionalprinting technology. Chin Tradit Pat Med (�г�ҩ), 2007(3):355-359. LIU Z, SUN M J. The first listed antiepileptic drug manufactured by 3D printing-spritam. J Pharm Res (ҩѧ�о�), 2015(9):556-558. RAZELLE K, DAVID J. Spritam--a new formulation of levetiracetam for epilepsy. Med Lett Drugs Ther, 2016,58(1497):78-79. HOFFMAN A. Pharmacodynamic aspects of sustained release preparations. Adv Drug Deliv Rev, 1998,33(10):185-186. KATSTRA W E, PALAZZOLO R D, ROWE C W, et al. Oral dosage forms fabricated by three dimensional printing. J Controlled Release, 2000,66(1):1-9. WANG C C, TEJWANI M M, ROACH W J, et al. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology. Drug Dev Ind Pharm, 2006,32(3):367-376. YU D G, YANG X L, HUANG W D, et al. Tablets with material gradients fabricated by three-dimensional printing. J Pharm Sci,2007,96(9):2446-2456. BRAYDEN D J. Controlled release technologies for drug delivery . Drug Discov Today, 2003,8(5):976-978. ROWE C W, KATSTRA W E, PALAZZOLO R D, et al. Multimechanism oral dosage forms fabricated by three dimensional printing. J Controlled Release, 2000,66(1):11-17. GROOT N L, SPIEGEL B M, HAALEN H G, et al. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components. Value Health, 2013,16(5):769-777. YU D G. Studies on novel oral controlled-release drug delivery systems using three-dimensional printing . Wuhan;Huazhong University of Science and Technology, 2007. LIN S, CHAO P Y, CHIEN Y W, et al. In vitro and in vivo evaluations of biodegradable implants for hormone replacement therapy: effect of system design and PK-PD relationship. AAPS Pharm Sci Tech, 2001,2(3):55-65. HUANG W, ZHENG Q, SUN W, et al. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int J Pharm, 2007,339(1-2):33-38. CASTILHO M, MOSEKE C, EWALD A, et al. Direct 3D powder printing of biphasic calcium phosphate scaffolds for substitution of complex bone defects. Biofabrication, 2014,6(1):15006. WU G, WU W, ZHENG Q, et al. Experimental study of PLLA/INH slow release implant fabricated by three dimensional printing technique and drug release characteristics in vitro. Biomed Eng Online, 2014,13(1):97-108. ZHANG X Y. Exploration on current status,problems and possible solutions of personalized medicine . Qilu Pharm Aff(��³ҩ��), 2012(12):719-721. LEE B K, YUN Y H, CHOI J S, et al. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system. Int J Pharm, 2012,427(2):305-310. BUANZ A B, SAUNDERS M H, BASIT A W, et al. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing. Pharm Res, 2011,28(10):2386-2392. BUANZ A B M. Pharmaceutical applications of thermal inkjet printing. University College London, 2014. ELELE E, SHEN Y, SUSARLA R, et al. Electrodeless electrohydrodynamic drop-on-demand encapsulation of drugs into porous polymer films for fabrication of personalized dosage units. J Pharm Sci, 2012,101(7):2523-2533. WICKSTROM H, PALO M, RIJCKAERT K, et al. Improvement of dissolution rate of indomethacin by inkjet printing. Eur J Pharm Sci, 2015,75(7):91-100. KHALED S A, BURLEY J C, ALEXANDER M R, et al. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm, 2014,461(1-2):105-111. KHALED S A, BURLEY J C, ALEXANDER M R, et al. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Controlled Release, 2015,217(9):308-314. SKOWYRA J, PIETRZAK K, ALHNAN M A. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci, 2015,68(2):11-17. GOYANES A, BUANZ A B, BASIT A W, et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm, 2014,476(1-2):88-92. SKOWYRA J, PIETRZAK K, ALHNAN M A. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci, 2015,68(2):11-17. GOYANES A, WANG J, BUANZ A, et al. 3D printing of medicines:engineering novel oral devices with unique design and drug release characteristics. Mol Pharm, 2015,12(11):4077-4084. PIETRZAK K, ISREB A, ALHNAN M A. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm, 2015,96(10):380-387. SANDLER N, KASSAMAKOV I, EHLERS H, et al. Rapid interferometric imaging of printed drug laden multilayer structures. Sci Rep, 2014,4:42-45. GENINA N, HOLLANDER J, JUKARAINEN H, et al. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur J Pharm Sci, 2015,90(7):53-63. LIUHT. Studyonthe processing materialsof UV-euring three��dimensional printing . Wuhan; Huazhong University of Science and Technology, 2009. JIE W, GOYANES A, GAISFORD S, et al. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm, 2016,503(1-2):207-212. LU Y, MANTHA S N, CROWDER D C, et al. Microstereolithography and characterization of poly(propylene fumarate)-based drug-loaded microneedle arrays. Biofabrication, 2015,7(4):45001.
2017, Vol. 52 
